ABT—1Q18 sales of branded generics +7% YoY in constant currency (+10% YoY in USD), led by >10% increases in India, China, and Brazil: http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyNjk3MzV8Q2hpbGRJRD02OTE5NzA= The stock is off slightly today because ABT did not raise 2018-full-year (non-GAAP) EPS guidance; it remains $2.80-2.90.